Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Barsan

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
JAMA Neurology|April 30, 2019
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical TrialHolly Tillman, S Claiborne Johnston, Mary Farrant, et al.
The New England Journal of Medicine|May 17, 2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIAS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
JAMA|July 24, 2019
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical TrialKaren C Johnston, Askiel Bruno, Qi Pauls, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 25, 2013
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and designS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Clinical Trials (London, England)|June 14, 2014
Screen failure data in clinical trials: Are screening logs worth it?Jordan J Elm, Yuko Palesch, J Donald Easton, et al.
The New England Journal of Medicine|November 28, 2019
Randomized Trial of Three Anticonvulsant Medications for Status EpilepticusJaideep Kapur, Jordan Elm, James M Chamberlain, et al.
Research Methods in Medicine & Health Sciences|April 3, 2023
Statistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker studiesLeonidas E Bantis, Kate J Young, John V Tsimikas, et al.
Journal of Neurotrauma|December 15, 2020
Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III TrialFrederick Korley, Qi Pauls, Sharon D Yeatts, et al.
Lancet (London, England)|March 24, 2020
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trialJames M Chamberlain, Jaideep Kapur, Shlomo Shinnar, et al.
Stroke|June 23, 2020
Efficacy of Clopidogrel for Prevention of Stroke Based on <i>CYP2C19</i> Allele Status in the POINT TrialJames F Meschia, Ronald L Walton, Luca P Farrugia, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
JAMA Neurology|April 30, 2019
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical TrialHolly Tillman, S Claiborne Johnston, Mary Farrant, et al.
The New England Journal of Medicine|May 17, 2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIAS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
JAMA|July 24, 2019
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical TrialKaren C Johnston, Askiel Bruno, Qi Pauls, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 25, 2013
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and designS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Clinical Trials (London, England)|June 14, 2014
Screen failure data in clinical trials: Are screening logs worth it?Jordan J Elm, Yuko Palesch, J Donald Easton, et al.
The New England Journal of Medicine|November 28, 2019
Randomized Trial of Three Anticonvulsant Medications for Status EpilepticusJaideep Kapur, Jordan Elm, James M Chamberlain, et al.
Research Methods in Medicine & Health Sciences|April 3, 2023
Statistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker studiesLeonidas E Bantis, Kate J Young, John V Tsimikas, et al.
Journal of Neurotrauma|December 15, 2020
Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III TrialFrederick Korley, Qi Pauls, Sharon D Yeatts, et al.
Lancet (London, England)|March 24, 2020
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trialJames M Chamberlain, Jaideep Kapur, Shlomo Shinnar, et al.
Stroke|June 23, 2020
Efficacy of Clopidogrel for Prevention of Stroke Based on <i>CYP2C19</i> Allele Status in the POINT TrialJames F Meschia, Ronald L Walton, Luca P Farrugia, et al.
Pageof 3